Nucleai vs TrialJectory
Nucleai vs TrialJectory, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nucleai is on 63/100 and TrialJectory on 58/100.
Where each one leads
Nucleai
- our overall score: 63/100 against 58/100
- agent readiness: 42/100 against 32/100
- headcount: 66 against 17
- headcount growth: -7.0% against -33.1%
- funding raised: $58.5M against $39.7M
- LinkedIn following: 18,902 against 4,387
TrialJectory
- domain rating: 39/100 against 29/100
At a glance
| Measure | Nucleai | TrialJectory |
|---|---|---|
| What it is | AI-powered spatial biology platform for precision medicine and drug development. | AI-powered platform connecting cancer patients to advanced treatments and clinical trials. |
| Category | Healthcare, Oncology, Pharmaceutical, HealthTech | Healthcare, Clinical Trials, Cancer, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2017 |
| Headquarters | Tel Aviv, Israel | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Nucleai | TrialJectory |
|---|---|---|
| Employees | 66 | 17 |
| Headcount growthLast 12 months | -7.0% | -33.1% |
| Total funding | $58.5M | $39.7M |
| Latest round | Series B | Series A |
| LinkedIn followers | 18,902 | 4,387 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Nucleai | TrialJectory |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 58/100 |
| Traction | 57/100 | 51/100 |
| Team | 70/100 | 70/100 |
| Community | 8/100 | Not published |
| Search visibility | 31/100 | 36/100 |
| Quality | 68/100 | 62/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 29/100 | 39/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Nucleai | TrialJectory |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Not detected | CloudFront |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Next.js |
| Analytics | Google Tag Manager, Linkedin Insight, Facebook Pixel | Not detected |
| Support stack | HubSpot | Not detected |
Nucleai vs TrialJectory: common questions
Which is better, Nucleai or TrialJectory?
On our 0-100 score Nucleai rates higher (63/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Nucleai and TrialJectory compare on the numbers?
Nucleai leads on our overall score (63/100 against 58/100), agent readiness (42/100 against 32/100), headcount (66 against 17), headcount growth (-7.0% against -33.1%), funding raised ($58.5M against $39.7M), LinkedIn following (18,902 against 4,387). TrialJectory leads on domain rating (39/100 against 29/100).
Read the full Nucleai review and pricing or the TrialJectory review and pricing. You can also browse other Nucleai alternatives we track.